Taiwan firm Delta, A*Star launches diagnostics lab in Singapore

Singapore: Taiwan based Delta Electronics has invested in Singapore to develop next-generation infectious disease detec...

January 16, 2015 | Friday | News
Asia witnessing rise in COPD, says Dr David Price

Professor (Dr) David Price has been fighting the scourge of respiratory diseases throughout his life and is considered o...

July 6, 2012 | Friday | Influencers
Eli Lilly opens diabetes R&D center in China

Singapore: Eli Lilly officially opened the Lilly China Research and Development Center (LCRDC) on May 30, keeping with i...

June 1, 2012 | Friday | News
Aussie firm progresses with cancer anorexia drug

Singapore: Australia-based biopharmaceutical company, Specialised Therapeutics Australia (STA), has achieved positive re...

September 29, 2014 | Monday | News
Alchemia recruits patients for rectal cancer trial

Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...

February 5, 2013 | Tuesday | News
Non-Small Cell Lung Cancer treatment market to touch $7.9 bn by 2020'

Singapore: Global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from USD5.1 billion in 2013 to...

September 11, 2014 | Thursday | Analysis
Amid rising concern, need for novel antibiotics

Singapore: Recent worries over antibiotics losing their effectiveness will only be exacerbated by the FDA's latest drug ...

March 14, 2013 | Thursday | Analysis
Bristol seeks Japanese nod of all-oral hepatitis C treatment

Singapore: US drugmaker, Bristol-Myers Squibb co has said that it is seeking Japanese health regulators approval of its ...

November 4, 2013 | Monday | Regulatory
Orphan blood disease drugs to gain market

Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This...

February 7, 2013 | Thursday | Analysis
German, Korean firm join hands to discover cancer drugs

Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence ...

June 4, 2015 | Thursday | News
BMS, Pfizer gets FDA nod to review Eliquis

Singapore: U.S. Food and Drug Administration (FDA) has accepted to review Supplemental New Drug Application (sNDA) for E...

July 12, 2013 | Friday | Regulatory
Eisai expands R&D in Belgium with office in Brussels

Singapore: Eisai EMEA (Europe, Middle East, Africa, Russia and Oceania), the R&D division of the Japan-based company...

September 16, 2013 | Monday | News
Genzyme's Cerdelga capsules approved in Japan

Genzyme, a Sanofi company, announced that the Ministry of Health, Labour and Welfare (MHLW) has granted marketing approv...

April 1, 2015 | Wednesday | News
GE to open technology and training centre in Turkey

Singapore: GE Healthcare Life Sciences plans to open a technology and training laboratory in Turkey by mid-2015 targetti...

November 17, 2014 | Monday | News
Takeda terminates prostrate cancer drug trial

Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...

June 24, 2014 | Tuesday | News
Panacea JV to yield generics revenue of $25 bn

New Delhi: Panacea Biotec entered into a strategic alliance for R&D and commercialization of drug delivery-based, ge...

September 12, 2012 | Wednesday | News
Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...

August 14, 2013 | Wednesday | Company results
Military univ, Shanghai Pharma form alliance

Singapore: Shanghai Pharmaceuticals has entered into a strategic framework cooperation agreement with Secondary Military...

August 1, 2013 | Thursday | News